ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 981

Adipocytokines and Obesity in the Context of Rheumatoid and Osteoarthritis Mouse Models

Hani Manfred Sauermilch1, Marie-Lisa Hülser 1, Carina Schreiyäck 1, Yubin Luo 2, Aline Bozec 2, Georg Schett 3, Ulf Müller-Ladner 4 and Elena Neumann 5, 1Dept. of Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus-Liebig-University Giessen, Germany, Giessen, Germany, 2Department Clinic of Medicine 3 - Immunology and Rheumatology, University of Erlangen-Nürnberg, Erlangen, Germany, Erlangen, Germany, 3Department of Internal Medicine 3, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany, 4Justus Liebig University Gießen, Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, Bad Nauheim, Germany, Gießen, Hessen, Germany, 5Justus Liebig University Gießen, Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, Bad Nauheim, Germany, Giessen, Hessen, Germany

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Animal models, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: RA – Animal Models Poster

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Adipocytokines are bioactive factors mainly produced by adipose tissue and exert many important effects on energy homeostasis as well as immune responses. Osteoarthritis (OA) is one of the most common degenerative joint diseases whereas rheumatoid arthritis (RA) is a chronic autoimmune joint disease. To evaluate the role of adipokines and obesity in the setting of both diseases at different time points, we combined an obesity model (high-fat diet, HFD) with a model for OA (DMM, destabilization of the medial meniscus) and RA (collagen induced arthritis, CIA).

Methods: The DMM model was performed in C57Bl/6 mice fed with HFD or ND (normal diet) prior to OA induction. In the CIA model, DBA/1Rj mice were fed with the same diets for 12 (DMM) and 6 (CIA) weeks prior to CIA induction. Mice were sacrificed to collect histological as well as serological data after 4, 6 and 8 weeks (DMM model) or after 4, 5.5 and 7 weeks (CIA model) after arthritis induction. Histological scoring for arthritis induction (both models) and assessment of a clinical score for the CIA model was performed. Serum concentrations of CRP, the adipokines adiponectin, leptin and visfatin were measured. Immunohistochemical stainings were performed to evaluate local adipokine distribution in the joints. Diet-induced systemic changes were analyzed using a fatty liver score and evaluation of crown-like structures (CLS) in adipose tissue.

Results: Induction of OA/ RA was successfully established in an HFD setting, shown by the histological joint destruction and the increased fatty liver score and bodyweight, respectively. In DMM, the number of CLS were significantly higher in the HFD group (0.2 ± 0.16, n=7) compared to the ND group (5.2 ± 0.98, n=8). However, CIA induction increased the number of CLS in HFD (2.77 ± 1.07, n=6) and especially in ND animals (8.14 ± 0.23, n=5) compared to healthy ND mice (0.45 ± 0.03, n=4) and healthy HFD mice (2.57 ± 0.53, n=4) without CIA induction. With regard to healthy animals, CRP serum levels were significantly increased in mice after CIA induction. Interestingly, CIA and DMM induction decreased systemic leptin levels significantly which could not be observed in the local leptin distribution in the joints (CIA).

Conclusion: Our data show that OA is deteriorated by HFD, similar to observations in humans. Histological CIA scoring showed no significant difference in CIA severity under HFD or ND. The high numbers of CLS in CIA animals with ND and the strong reduction of serum leptin levels in CIA animals with HFD indicates that CIA onset and severity are mainly obesity independent while OA (DMM) appears to be influenced by obesity. Interestingly, systemic and local adipokine concentrations did not match in DMM as well as the CIA model. This data suggests a time-dependent adipokine expression and segregation of local and systemic adipokine effects in the context of RA and OA.


Disclosure: H. Sauermilch, None; M. Hülser, None; C. Schreiyäck, None; Y. Luo, None; A. Bozec, None; G. Schett, AbbVie, BMS, Celgene, Janssen, Lilly, Novartis, Pfizer, 8, AbbVie, BMS, Celgene, Janssen, Lilly, Novartis, UCB, 5, BMS, Celgene, GSK, Lilly, Novartis, 2; U. Müller-Ladner, None; E. Neumann, None.

To cite this abstract in AMA style:

Sauermilch H, Hülser M, Schreiyäck C, Luo Y, Bozec A, Schett G, Müller-Ladner U, Neumann E. Adipocytokines and Obesity in the Context of Rheumatoid and Osteoarthritis Mouse Models [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/adipocytokines-and-obesity-in-the-context-of-rheumatoid-and-osteoarthritis-mouse-models/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/adipocytokines-and-obesity-in-the-context-of-rheumatoid-and-osteoarthritis-mouse-models/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology